Solera network participants enrolled in
diabetes prevention programs who used Fitbit devices had higher
activity levels and increased weight loss
New Fitbit Inspire and Fitbit Inspire HR
activity trackers are now available to all Solera participants
enrolled in a diabetes prevention program
Fitbit (NYSE:FIT), the leading global wearables brand, and
Solera Health, an integrated benefit network, announced they have
expanded their partnership to reduce the risk of type 2 diabetes by
using the Fitbit platform through Solera Health’s innovative model
to encourage positive behavior changes, such as increased physical
activity and weight loss. Based on an analysis of more than 1,700
people who enrolled in the National Diabetes Prevention Program
(DPP) through the Solera network, Solera found that participants
who redeemed a Fitbit device were more active and lost more weight
during the program than those who did not. Now, the companies are
making the latest Fitbit devices, Fitbit Inspire™ and Inspire HR™,
available to all Solera DPP participants, including Medicare and
Medicaid beneficiaries.
Type 2 diabetes affects more than 30 million American adults and
costs the U.S. approximately $327 billion annually in direct
medical expenses and lost productivity.i Yet, the onset of disease
can be delayed – or even prevented – among the 84 million U.S.
adults at high risk for developing type 2 diabetes.ii Research has
shown that people with prediabetes who lost 5% of their body weight
through healthier eating and 150 minutes of activity per week cut
their risk of developing type 2 diabetes in half.iii This
intervention strategy is the foundation of the Centers for Disease
Control and Prevention’s National DPP, which is now a covered
preventive service for all Medicare beneficiaries.
Solera brings a proven business model to the partnership with
Fitbit that solves for scale and personalization. Solera contracts
with health plans and employers to match individuals with the
best-fit digital or community-based DPP that meets each person’s
unique needs and preferences. To date, Solera has enrolled over
100,000 people in the National DPP through its network model.
“At Fitbit, we have spent the last 12 years empowering people to
live healthier lives, and we believe that a proactive approach is
essential to the prevention and management of type 2 diabetes,”
said Adam Pellegrini, general manager, Fitbit Health Solutions. “We
are focused on addressing some of the most common and costly
conditions in healthcare – and diabetes is a top priority. Through
our work with Solera over the past two years, we have shown that
Solera’s model, based on proven health outcomes, coupled with our
innovative devices, motivating platform and proven behavior change
principles, is an effective combination for preventing type 2
diabetes.”
Beginning in 2017, Solera began offering Fitbit devices to
individuals who used Solera to enroll in community-based or digital
DPPs. Solera conducted an analysis of more than 1,700 people who
enrolled between January 1, 2017 and March 31, 2017.
Key findings from the Solera analysis include:
- At the one-year mark, DPP participants
who redeemed a Fitbit device lost a larger percent of their
starting weight than non-Fitbit participants (-3.38% vs
-2.27%, p=0.013) and were much more likely to achieve the 5%
weight loss milestone compared to those who did not (51% vs 36%,
p=<0.001).
- By weeks 10-16, DPP participants who
redeemed a Fitbit device reported an extra 60 minutes of weekly
activity compared to non-Fitbit participants and continued to
report at least 45 minutes more weekly activity through the
maintenance phase of the program in months 6-12.
- Participants age 60-69 years old were
more likely than any other age group included in the analysis to
redeem a Fitbit device through the program, which is significant
given that 61% of all healthcare costs attributed to diabetes care
are for people over age 65.iv
The analysis shows that Fitbit devices can play a meaningful
role in improving health outcomes for participants in DPPs. Based
on the success of the partnership to date, Fitbit and Solera are
exploring additional opportunities to scale their collaboration in
2019, including offering Fitbit’s latest activity trackers, Fitbit
Inspire™ and Fitbit Inspire HR™, to Solera’s DPP participants.
“Solera is thrilled to enter a strategic partnership with Fitbit
as there are many market synergies between what the two companies
are doing to improve the health of those at risk for type 2
diabetes,” said Brenda Schmidt, CEO of Solera Health. “Our unique
ability to connect individuals with the best-fit DPP to meet their
needs and preferences, paired with Fitbit’s easy-to-use wearable
devices, has the potential to significantly alter how populations
approach chronic disease prevention and management. We look forward
to scaling this partnership further in order to help future program
participants maintain and improve their health.”
Fitbit Inspire™ and Fitbit Inspire HR™ were designed for and
made available first to health plans, employers and health systems.
They meet the specific needs of the healthcare industry with a
sleek, easy-to-use tracker form factor, core health and fitness
features, cross-platform compatibility, up to 5 days battery lifev
and the software and social experience that motivate users at an
approachable price point. The devices are currently available to
plan members and employees of Fitbit Health Solutions partners and
customers, including Humana, Adobe, and Domino’s, among others.
About Solera Health
Solera Health is committed to changing lives by guiding people
to better health in their communities. The company serves as an
integrated benefit network that connects patients, payers and
physicians with community organizations and digital therapeutics
providers, simply and securely. Solera helps consolidate
highly-fragmented programs and services into a single marketplace
allowing health plans and medical providers to increase consumer
participation while lowering associated costs. By using data
science to proactively identify the "best fit" program provider
based on each individual's unique health goals, needs and
preferences, the company has proven to have a significant impact on
improved patient outcomes at a fraction of the cost of traditional
medical care. For more information, visit Solera Health at
www.soleranetwork.com, call 800-858-1714 or follow us on Twitter
@SoleraNetwork or LinkedIn.
About Fitbit
Fitbit helps people lead healthier, more active lives by
empowering them with data, inspiration and guidance to reach their
goals. As the leading global wearables brand, Fitbit designs
products and experiences that track and provide motivation for
everyday health and fitness. Fitbit’s diverse line of innovative
and popular products include Fitbit Charge 3™, Fitbit Inspire HR™,
Fitbit Inspire™, Fitbit Ace 2™, activity trackers, as well as the
Fitbit Ionic™ Fitbit Versa™ smartwatches, Fitbit Flyer™ wireless
headphones and Fitbit Aria 2™ Wi-Fi Smart Scale. Fitbit products
are carried in over 39,000 retail stores and in 87 countries around
the globe. Powered by one of the world’s largest social fitness
networks and databases of health and fitness data, the Fitbit
platform delivers personalized experiences, insights and guidance
through leading software and interactive tools, including the
Fitbit and Fitbit Coach apps, and the Fitbit OS for smartwatches.
Fitbit Health Solutions develops health and wellness solutions
designed to help increase engagement, improve health outcomes, and
drive a positive return for employers, health plans and health
systems.
Fitbit and the Fitbit logo are trademarks or registered
trademarks of Fitbit, Inc. in the U.S. and other countries.
Additional Fitbit trademarks can be found at
www.fitbit.com/legal/trademark-list. Third-party trademarks are the
property of their respective owners.
Connect with us on Facebook, Instagram or Twitter and share your
Fitbit experience.
Forward-Looking Statements
This press release contains forward-looking statements, within
the meaning of the safe harbor provisions of the Private Securities
Litigation Reform Act of 1995, that involve risks and uncertainties
including, among other things, statements regarding future research
initiatives using Fitbit devices. These forward-looking statements
are only predictions and may differ materially from actual results
due to a variety of factors, including the effects of the highly
competitive market in which we operate, including competition from
much larger technology companies; any inability to successfully
develop and introduce new products, features, and services or
enhance existing products and services; product liability issues,
security breaches or other defects; and other factors discussed
under the heading “Risk Factors” in our most recent report on Form
10-Q filed with the Securities and Exchange Commission. All
forward-looking statements contained herein are based on
information available to us as of the date hereof and we do not
assume any obligation to update these statements as a result of new
information or future events.
i American Diabetes Association. The Cost of Diabetes. Accessed
February 20, 2019.
http://www.diabetes.org/advocacy/news-events/cost-of-diabetes.html
ii Centers for Disease Control. Research-Based Prevention
Program. Accessed February 20, 2019.
https://www.cdc.gov/diabetes/prevention/prediabetes-type2/index.html
iii Centers for Disease Control. Research-Based Prevention
Program. Accessed February 20, 2019.
https://www.cdc.gov/diabetes/prevention/prediabetes-type2/preventing.html
iv American Diabetes Association. Economic Costs of Diabetes in
2017. Diabetes Care. 2018 May; 41(5): 917-928. Accessed March 4,
2019. http://care.diabetesjournals.org/content/41/5/917
v Battery life varies with use and other factors
View source
version on businesswire.com: https://www.businesswire.com/news/home/20190306005250/en/
Fitbit, Inc.Jen Ralls, 415-941-0037PR@fitbit.com
Fitbit (NYSE:FIT)
Historical Stock Chart
From Jun 2024 to Jul 2024
Fitbit (NYSE:FIT)
Historical Stock Chart
From Jul 2023 to Jul 2024